Science Corporation, the company founded by Max Hodak following his departure from Neuralink, has implanted its vision-restoring chip in its first patient with Stargardt disease, a degenerative eye condition that causes progressive vision loss.
Hodak, former president and co-founder of Neuralink, detailed the company's work with PRIMA during a presentation at TechCrunch Disrupt. PRIMA represents the company's approach to developing a brain-computer interface technology aimed at restoring vision to patients with certain forms of blindness.
Stargardt disease affects the macula, the central part of the retina responsible for sharp, detailed vision. The condition typically begins in childhood or early adulthood and leads to significant vision impairment over time. Science Corporation's implant represents an attempt to bypass damaged photoreceptor cells and directly interface with the visual system.
The company's technology builds on work in visual prosthetics and neural interfaces. By implanting a chip that can decode visual information and communicate with the brain, Science Corporation aims to enable patients to perceive visual signals even when their natural retinas cannot function properly.
Hodak founded Science Corporation after stepping away from Neuralink, where he served as president alongside Elon Musk. His new venture focuses specifically on vision restoration through implantable technology, representing a specialized application of brain-computer interface research.
The successful implantation in the first Stargardt disease patient marks a clinical milestone for the company. Details about the patient's outcomes, the specific capabilities restored, and the timeline for additional implants remain part of the company's ongoing clinical work.
Science Corporation's progress in this area reflects broader momentum in neural interface technology for medical applications. The vision restoration field has seen increased investment and development activity, with multiple companies pursuing different technological approaches to address various forms of vision loss and blindness.